Howard Hughes Medical Institute’s Norwegian Cruise Line NCLH Stock Holding History

Howard Hughes Medical Institute’s Portfolio NCLH Stock Details NCLH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-98	Closed	-$2.19K	–	333
2025 Q4	$2.19K	Buy	98 +1	+1%	+$21	﹤0.01%	470
2025 Q3	$2.39K	Buy	97 +2	+2%	+$49	﹤0.01%	451
2025 Q2	$1.93K	Buy	+95	New	+$1.7K	﹤0.01%	469

Other funds holding NCLH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Howard Hughes Medical Institute's NCLH Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Norwegian Cruise Line (NCLH) in Q1 2026, closing a stake of 98 shares — an estimated $2.19K sold.

Howard Hughes Medical Institute first reported a position in NCLH in Q2 2025 and held it in 3 quarters. The position peaked at $2.39K in Q3 2025. 635 funds tracked by Wall St. Rank hold NCLH as of Q1 2026.

Howard Hughes Medical Institute reported no remaining Norwegian Cruise Line position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 98 Norwegian Cruise Line shares in Q1 2026, an estimated $2.19K.
Howard Hughes Medical Institute first reported a position in Norwegian Cruise Line in Q2 2025 and held it in 3 quarters.
Howard Hughes Medical Institute's Norwegian Cruise Line position peaked at $2.39K in Q3 2025.
635 funds tracked by Wall St. Rank held Norwegian Cruise Line as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.